Smart Investing Blog2023-08-31T12:12:29+00:00
1109, 2024

The Presidential Debate is Affecting Trump’s Media Company: 3 Things DJT Investors Need to See

By |September 11th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

The debate America has long been anticipating took place last night between former president Donald Trump and current Vice President Kamala Harris.  The general consensus as of Wednesday morning is that Trump put on a somewhat rocky performance, with many believing Harris performed better than expected. Even conservative voters aren’t thrilled with what they saw from their candidate. Shares [...]

1009, 2024

What the EU’s Court Verdict Means for Apple: Plus, 3 Other Things for AAPL Investors to Consider

By |September 10th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

It was a bad day for tech companies in the European Union (EU) court system as both Apple (AAPL) and Google (GOOGL) lost their battles and will face hefty financial penalties as a result. Apple was fighting a €13 billion ($14.4 billion) Irish tax bill, which can be traced all the way back to 2016. CEO Tim Cook says [...]

909, 2024

Average Return Selling Covered Calls

By |September 9th, 2024|Categories: Options|Tags: , , |

Of all the different ways to make money with options, selling covered calls has become increasingly popular for its consistency and ease of implementation. It’s a great way to earn supplemental income on a stock you own that isn’t moving much. But, let’s get more specific. What is the average return selling covered calls? A quick scan of the web [...]

609, 2024

Vaxcyte Trial Results Suggest it Could Compete With Pfizer: Is it Worth Buying This Stock Today?

By |September 6th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Earlier this week Vaxcyte (PCVX) shared an update on its VAX-31 trial results, which are quite promising. The stock popped nearly 50% on the news, sending shares to an all-time high of $115/share.  VAX-31 is the company’s pneumococcal conjugate vaccine. This disease can contribute to more serious illnesses such as pneumonia, meningitis, and various ear and sinus infections.  The [...]

509, 2024

4 Critical Steps to Protect and Profit from NVIDIA Investments Now

By |September 5th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Market in Review, Stock Market News|Tags: , , , , , , , , |

NVIDIA’s role as a leader in the AI revolution makes it one of the most exciting stocks on the market. With a market cap over $1 trillion and its presence in everything from data centers to gaming, it’s a stock that many investors have their eyes on—whether you already own it or are thinking about buying it for the [...]

509, 2024

Tesla Stock is Up 13% in the Past Week, Outpacing Peers and the Market as a Whole: Time to Buy?

By |September 5th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , |

It’s been a rollercoaster ride so far this year for Tesla (TSLA) investors, as the stock has seen thrilling highs and concerning lows.  The stock fell roughly 40% in a single month over the summer, but has since begun its road to recovery. It’s up 17% in the past month, and looks to be continuing its trend in the [...]

Analyze Any Stock Free

30-DAY TRIAL

  • FREE MOBILE APP
  • FREE COACHING
  • FREE QUICK START COURSE
Ready to test-drive VectorVest? Sign up now and
try a simpler approach to picking the right stocks.
Go to Top